Literature DB >> 29196882

The GABRB3 Polymorphism and its Association with Schizophrenia.

Yi Liu1, Xue-Fei Sun1, Mei Ding1, Yong-Ping Liu1, Xi-Cen Zhang1, Hao Pang1, Jia-Xin Xing1, Jin-Feng Xuan1, Xi Xia1, Bao-Jie Wang2, Jun Yao3.   

Abstract

The aim of this study was to explore whether schizophrenia occurrence is associated with polymorphisms in the 5' regulatory region of GABRB3 (gamma-aminobutyric acid type A receptor beta 3, subunit gene). The study included 324 patients with schizophrenia and 327 unaffected participants; all individuals were northern Han Chinese. Genotype and haplotype frequency distributions were compared for the 2 groups by means of PCR amplification and direct sequencing of the promoter region of GABRB3. The genotype distribution among control participants was in accordance with the Hardy-Weinberg equilibrium. Five common single-nucleotide polymorphism (SNP) sites were detected in the 5' promoter region of GABRB3: rs4243768, rs7171660, rs4363842, rs4906902, and rs8179184. Only rs8179184 and rs4906902 differed significantly in frequency between controls and cases (P < 0.05); this difference remained significant when only women in each group were compared. The 2 SNP sites showed linkage disequilibrium, resulting in 2 haplotypes: T-G and C-A. The frequency of C-A was significantly higher among patients with schizophrenia than among controls. Our findings suggest that rs4906902 and rs8179184 in the 5' promoter region of GABRB3 are associated with schizophrenia. The C-A haplotype may entail an increased risk of schizophrenia, and the onset of schizophrenia may be gender-specific.

Entities:  

Keywords:  GABRB3; Schizophrenia; Single-nucleotide polymorphisms (SNPs); γ-Aminobutyric acid

Mesh:

Substances:

Year:  2017        PMID: 29196882     DOI: 10.1007/s12031-017-1003-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Recent segmental duplications in the human genome.

Authors:  Jeffrey A Bailey; Zhiping Gu; Royden A Clark; Knut Reinert; Rhea V Samonte; Stuart Schwartz; Mark D Adams; Eugene W Myers; Peter W Li; Evan E Eichler
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

2.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

3.  [Polymorphisms of rs4906902 and rs8179184 loci in the promoter of the GABRB3 gene and their relevance with schizophrenia].

Authors:  Xue-fei Sun; Mei Ding; Ying Sun; Hao Pang; Jin-feng Xuan; Jia-xin Xing; Chun-mei Li; Bao-jie Wang
Journal:  Fa Yi Xue Za Zhi       Date:  2012-06

Review 4.  Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.

Authors:  Rhonda P Patrick; Bruce N Ames
Journal:  FASEB J       Date:  2015-02-24       Impact factor: 5.191

5.  Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3.

Authors:  Timothy M DeLorey; Peyman Sahbaie; Ezzat Hashemi; Wen-Wu Li; Ahmad Salehi; David J Clark
Journal:  Behav Brain Res       Date:  2010-08-10       Impact factor: 3.332

6.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

7.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 8.  GABA and schizophrenia: a review of basic science and clinical studies.

Authors:  Adel Wassef; Jeffrey Baker; Lisa D Kochan
Journal:  J Clin Psychopharmacol       Date:  2003-12       Impact factor: 3.153

Review 9.  Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

Authors:  Heike Tost; Tajvar Alam; Andreas Meyer-Lindenberg
Journal:  Neurosci Biobehav Rev       Date:  2009-06-24       Impact factor: 8.989

Review 10.  GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; Kenneth N Fish; David A Lewis
Journal:  Neural Plast       Date:  2011-09-05       Impact factor: 3.599

View more
  4 in total

1.  Association between C-Maf-inducing protein gene rs2287112 polymorphism and schizophrenia.

Authors:  Yingli Fu; Xiaojun Ren; Wei Bai; Qiong Yu; Yaoyao Sun; Yaqin Yu; Na Zhou
Journal:  PeerJ       Date:  2021-08-20       Impact factor: 2.984

2.  Functional analysis of haplotypes and promoter activity at the 5' region of the human GABRB3 gene and associations with schizophrenia.

Authors:  Yi Liu; Mei Ding; Yong-Ping Liu; Xi-Cen Zhang; Jia-Xin Xing; Jin-Feng Xuan; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  Mol Genet Genomic Med       Date:  2019-03-25       Impact factor: 2.183

3.  Association between EFHD2 gene polymorphisms and schizophrenia among the Han population in northern China.

Authors:  Meng Gao; Kuo Zeng; Ya Li; Yong-Ping Liu; Xi Xia; Feng-Ling Xu; Jun Yao; Bao-Jie Wang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

4.  Gabrb3 endothelial cell-specific knockout mice display abnormal blood flow, hypertension, and behavioral dysfunction.

Authors:  Anass Agrud; Sivan Subburaju; Pranay Goel; Jun Ren; Ashwin Srinivasan Kumar; Barbara J Caldarone; Wangde Dai; Jesus Chavez; Dai Fukumura; Rakesh K Jain; Robert A Kloner; Anju Vasudevan
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.